ClinConnect ClinConnect Logo
Search / Trial NCT06714760

Evaluation of the Galea-pericranium Flap in Reconstruction of Oral Cavity Defects

Launched by IRCCS AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA · Dec 3, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a new method for repairing defects in the gum area of the jaw, specifically using a special flap taken from the scalp. The goal is to see if this technique is safe for patients with certain types of gum problems related to the lower jaw. The study is currently looking for participants aged 18 and older who have specific gum defects but still have healthy jawbone structure.

To participate, individuals must have a gum defect in the front or side of their jaw and be willing to follow up with the study for at least three months. They should not have had previous surgeries that might affect blood flow in the scalp area. If eligible, participants will receive care related to their condition and will help researchers understand how effective and safe this new reconstruction method is for people with oral diseases.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients aged ≥18 years;
  • Patients with mandibular gingival defects involving the anterior or lateral aspect of the mandible;
  • Patients in whom basal structural integrity of the mandibular bone is maintained;
  • Patients with a minimum follow-up of 3 months;
  • Obtaining informed consent.
  • Exclusion Criteria:
  • • Patients with history of previous surgery that bilaterally altered the superficial temporal vasculature.

About Irccs Azienda Ospedaliero Universitaria Di Bologna

IRCCS Azienda Ospedaliero-Universitaria di Bologna is a prestigious research and healthcare institution in Italy, renowned for its commitment to advancing medical science and patient care through innovative clinical research. As an IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), it integrates clinical practice with scientific research, facilitating the translation of laboratory findings into effective treatment strategies. The institution fosters a multidisciplinary approach, collaborating with various experts to conduct high-quality clinical trials aimed at improving health outcomes across a wide range of medical fields. With a strong emphasis on ethical standards and patient welfare, IRCCS Azienda Ospedaliero-Universitaria di Bologna plays a vital role in shaping the future of medicine through rigorous scientific inquiry and patient-centered care.

Locations

Bologna, Emilia Romagna, Italy

Patients applied

0 patients applied

Trial Officials

Achille Tarsitano, MD

Principal Investigator

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported